Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chorionic somatomammotropin hormone-like 1 (CSHL1) is a member of the somatotropin/prolactin family of hormones encoded by the *CSHL1* gene on chromosome 17[4][8]. It is primarily expressed in the placenta and is structurally related to other growth hormone and lactogen genes in the same chromosomal cluster[4][8]. CSHL1 is believed to play a role as a novel gestational hormone, possibly compensating for deficiencies in other growth hormone/chorionic somatomammotropin cluster members during gestation[4][5][6]. While considered a protein-coding gene, most CSHL1 transcripts are non-coding or may not produce a secreted protein due to alternative splicing[4].\nThe biological function of CSHL1 is not fully established; it is thought to be involved in regulation of growth, lactation, and fetal metabolism, similar to other placental lactogen hormones, but specific data on functional roles or direct therapeutic targeting is lacking[4][5]. Mutations in related genes within the locus (but not specifically CSHL1) are associated with pregnancy-related diseases such as placental lactogen deficiency and Silver-Russell syndrome[1][4]. There are no known drugs that directly target CSHL1, nor established mechanisms of action for pharmacologic intervention or disease monitoring using CSHL1[4][6].\nCSHL1 is not a well-validated therapeutic target, and much of its function remains putative, with most sources considering it an *endogenous peptide hormone* of unclear physiologic significance in humans[4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chorionic somatomammotropin hormone-like 1 (CSHL1).